Ory, L. | IICIMED

Ory, L.

Publications

P201

Lipids Health Dis. 2019, 18, 168.

4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters.

Elia, J. | Carbonnelle, D. | Logé, C. | Ory, L. | Huvelin, J.-M. | Tannoury, M. | Diab-Assaf, M. | Petit, K. | Nazih, H.

doi: 10.1186/s12944-019-1103-7

P197

Mar. Drugs 2019, 17, 372.

Steroids from Marine-Derived Fungi: Evaluation of Antiproliferative and Antimicrobial Activities of Eburicol.

Dos Santos Dias, A. C. | Couzinet-Mossion, A. | Ruiz, N. | Lakhdar, F. | Etahiri, S. | Bertrand, S. | Ory, L. | Roussakis, C. | Pouchus, Y.-F. | Nazih, H. | Wielgosz-Collin, G.

doi:10.3390/md17060372

Autres publications scientifiques

Brevets

Thèse